Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04639583 · ClinicalTrials.gov registry record · NA
Use of NIRS in Preterm Population Born at Altitude
A NA study of Prematurity; Extreme, sponsored by University of New Mexi.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
- 1
- Study location
NCT04639583: Completed NA study of Prematurity; Extreme, sponsored by University of New Mexi.
NCT04639583 is a NA study of Prematurity; Extreme that has completed, run by University of New Mexi. The registered enrollment target is 21 participants, below the 242-participant average among 4 other Prematurity; Extreme trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04639583, a NA study of Prematurity; Extreme, has completed, sponsored by University of New Mexi.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
- 1
- Study location
Study Summary
Near-infrared spectroscopy (NIRS), is a technology that can provide continuous, non-invasive monitoring of oxygenation in tissue. The objective of this study is to obtain the cerebral regional oxygen saturation (cRSO2) in a preterm population that is born at altitude to determine if the range of "normal" values is different than those obtained at sea level.
Primary Outcome
Measure cRSO2 for the first 96 hours of life in infants born preterm.
Conditions Studied
Interventions
- DEVICE Near-infrared spectroscopy (NIRS) utilization
Study Locations (1)
New Mexico
- University of New Mexico - Albuquerque
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2021-10-01 |
| Est. Completion | 2023-06-30 |
| Phase | NA |
What the finished NCT04639583 record still lists
NCT04639583 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 21 participants, a relatively small participant target, below the 242-participant average among 4 other Prematurity; Extreme trials with a reported enrollment target (91% lower).
The record links to 1 condition, with Prematurity; Extreme appearing as the primary indexed condition, and to 1 intervention - of which Near-infrared spectroscopy (NIRS) utilization is the first listed.
NCT04639583 reports a single indexed study location in New Mexico.
Frequently Asked Questions
What is clinical trial NCT04639583 about?
NCT04639583 is a clinical study titled "Use of NIRS in Preterm Population Born at Altitude". Near-infrared spectroscopy (NIRS), is a technology that can provide continuous, non-invasive monitoring of oxygenation in tissue. The objective of this study is to obtain the cerebral regional oxygen saturation (cRSO2) in a preterm population that is born at altitude to determine if the range of "no...
What is the current status of trial NCT04639583?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2021-10-01. Estimated completion is 2023-06-30.
What conditions does trial NCT04639583 study?
This clinical trial studies the following conditions: Prematurity; Extreme.
What interventions are being tested in trial NCT04639583?
The interventions under investigation include: Near-infrared spectroscopy (NIRS) utilization (DEVICE).
Who is sponsoring clinical trial NCT04639583?
This trial is sponsored by University of New Mexi, which has 76 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04639583 being conducted?
This trial has 1 study location across New Mexico. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prematurity; Extreme
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Targeted Fortification of Donor Breast Milk in Preterm Infants
RECRUITING · NA
-
Early Protein Supplementation in Extremely Preterm Infants Fed Human Milk
ACTIVE NOT RECRUITING · NA
-
The Budesonide in Babies (BiB) Trial
ACTIVE NOT RECRUITING · Phase 3
-
Respiratory Outcomes After Early Vitamin D Supplementation in Infants Born Extremely Preterm
ACTIVE NOT RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI